Patents by Inventor Cheng Zhang

Cheng Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090181982
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
    Type: Application
    Filed: March 11, 2009
    Publication date: July 16, 2009
    Inventors: Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill, Lan Shen, Keith Demarest, Bruce R. Conway, David F. McComsey
  • Publication number: 20090176806
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
    Type: Application
    Filed: March 11, 2009
    Publication date: July 9, 2009
    Inventors: Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill, Lan Shen, Keith Demarest, Bruce R. Conway, David F. McComsey
  • Patent number: 7557348
    Abstract: A method and system for imaging an object includes transmitting distinguishable electromagnetic waves from a plurality of radiators of an antenna array, wherein each of the distinguishable electromagnetic waves is distinguishable from others by a detector. Each of the radiators transmits radiation comprising a different distinguishable electromagnetic wave. The method also includes imaging at least a portion of the antenna array onto a targeted object, wherein each image area of a plurality of image areas on the targeted object corresponds to an image of a respective radiator of the antenna array, and detecting a plurality of resultant electromagnetic waves, wherein the resultant electromagnetic waves are transmitted, scattered, or reflected by respective image areas on the targeted object in response to each of the respective image areas being illuminated by the radiation transmitted by the respective radiator of the source array.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: July 7, 2009
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Jingzhou Xu, Xi-Cheng Zhang
  • Publication number: 20090163527
    Abstract: The present invention is directed to a compound of Formula (I): or a form thereof, wherein X1, X2, X3, X4, R1, R2 and R3 are as defined herein, useful as tryptase inhibitors.
    Type: Application
    Filed: November 19, 2008
    Publication date: June 25, 2009
    Inventors: Michael J. Costanzo, Stephen C. Yabut, Brett Tounge, Bruce E. Maryanoff, Han-Cheng Zhang
  • Patent number: 7531802
    Abstract: A method of analyzing a remotely-located object includes the steps of inducing a volume of an ionized ambient gas to emit pulsed terahertz radiation directed toward a targeted object by focusing an optical pump beam in the volume and ionizing another volume of the ambient gas to produce a sensor plasma by focusing an optical probe beam in the other volume of ambient gas. The interaction, in the sensor plasma, of the focused optical probe beam and an incident terahertz wave, which is produced by the targeted object reflecting, scattering, or transmitting the pulsed terahertz radiation, produces a resultant radiation. Detecting an optical component of the resultant radiation emitted by the sensor plasma facilitates detection of a signature of the targeted object imposed onto the incident terahertz radiation.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: May 12, 2009
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Xi-Cheng Zhang, Jianming Dai, Xu Xie
  • Patent number: 7524858
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: April 28, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill, Lan Shen, David F. McComsey
  • Publication number: 20090093515
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
    Type: Application
    Filed: September 22, 2008
    Publication date: April 9, 2009
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye
  • Publication number: 20090093554
    Abstract: The particle sizes of agglomerates of carbon nanospheres are reduced by dispersing the carbon nanospheres in an organic solvent. The carbon nanospheres are multi-walled, hollow, graphitic structures with an average diameter in a range from about 10 nm to about 200 nm, more preferably about 20 nm to about 100 nm. Spectral data shows that prior to being dispersed, the carbon nanospheres are agglomerated into clusters that range in size from 500 nm to 5 microns. The clusters of nanospheres are reduced in size by dispersing the carbon nanospheres in an organic solvent containing at least one heteroatom (e.g., NMP) using ultrasonication. The combination of organic solvent and ultrasonication breaks up and disperses agglomerates of carbon nanospheres.
    Type: Application
    Filed: October 9, 2007
    Publication date: April 9, 2009
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Cheng Zhang, Bing Zhou
  • Publication number: 20090093582
    Abstract: Carbon nanostructures are formed from a carbon precursor and catalytic templating nanoparticles and are treated with a severe oxidative agent to introduce oxygen-containing functional groups to the surface of the graphitic material. Methods for manufacturing carbon nanostructures generally include (1) forming a precursor mixture that includes a carbon precursor and a plurality of catalytic templating particles, (2) carbonizing the precursor mixture to form an intermediate carbon material including carbon nanostructures, amorphous carbon, and catalytic metal, (3) purifying the intermediate carbon material by removing at least a portion of the amorphous carbon and optionally at least a portion of the catalytic metal, and (4) treating the intermediate carbon material with a severe oxidative treatment to increase surface functionalization.
    Type: Application
    Filed: October 9, 2007
    Publication date: April 9, 2009
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Cheng Zhang, Bing Zhou
  • Publication number: 20090093634
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
    Type: Application
    Filed: September 22, 2008
    Publication date: April 9, 2009
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye
  • Patent number: 7514476
    Abstract: Metal-containing colloids are manufactured by reacting a plurality of metal ions and a plurality of organic agent molecules to form metal complexes in a mixture having a pH greater than about 4.25. The metal complexes are reduced for at least 0.5 hour to form stable colloidal nanoparticles. The extended reduction time improves the stability of the colloidal particles as compared to shorter reduction times. The stability of the colloidal particles allows for colloids with higher concentrations of metal to be formed. The concentration of metal in the colloid is preferably at least about 150 ppm by weight.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: April 7, 2009
    Assignee: Headwaters Technology Innovation, LLC
    Inventors: Sukesh Parasher, Cheng Zhang, Michael A. Rueter, Bing Zhou
  • Publication number: 20090082474
    Abstract: The particle sizes of agglomerates of carbon nanospheres are reduced by dispersing the carbon nanospheres in a polar solvent. The carbon nanospheres are multi-walled, hollow, graphitic structures with an average diameter in a range from about 10 nm to about 200 nm, more preferably about 20 nm to about 100 nm. Spectral data shows that prior to being dispersed, the carbon nanospheres are agglomerated into clusters that range in size from 500 nm to 5 microns. The clusters of nanospheres are reduced in size by dispersing the carbon nanospheres in the polar solvent (e.g., water) using a surface modifying agent (e.g., glucose) and ultrasonication. The combination of polar solvent, surface modifying agent, and ultrasonication breaks up and disperses agglomerates of carbon nanospheres.
    Type: Application
    Filed: September 24, 2007
    Publication date: March 26, 2009
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Cheng Zhang, Bing Zhou
  • Publication number: 20090066948
    Abstract: Compact terahertz spectrometer. The spectrometer includes an optical beam both for generating terahertz radiation for interaction with the sample and for use in a detector. A DC heterodyne detector uses a DC field-induced second harmonic wave at a sensor plasma to serve as a local oscillator. The spectrometer has a bandwidth orders of magnitude larger than conventional THz spectrometers.
    Type: Application
    Filed: September 7, 2007
    Publication date: March 12, 2009
    Applicant: HYDROELECTRON VENTURES, INC.
    Inventors: Nicholas Karpowicz, Xi-Cheng Zhang, Keith H. Johnson, Matthew Price-Gallagher
  • Publication number: 20090060832
    Abstract: Hydrogen is stored by adsorbing the hydrogen to a carbon nanomaterial that includes carbon nanospheres. The carbon nanospheres are multi-walled, hollow carbon nanostructures with a maximum diameter in a range from about 10 nm to about 200 nm. The nanospheres have an irregular outer surface and an aspect ratio of less than 3:1. The carbon nanospheres can store hydrogen in quantities of at least 1.0% by weight.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 5, 2009
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Bing Zhou, Cheng Zhang
  • Patent number: 7495908
    Abstract: A mounting apparatus is provided for mounting a data storage device to a drive bracket. The data storage device is locked to the drive bracket via a locking module. The locking module includes a housing member attached to the drive bracket, and a pushing member, a locking member, and a releasing member that are attached to the housing member. The pushing member is driven by a pushing action of the data storage device for releasing the locking member in a first direction for locking the data storage device. The locking member is driven by the releasing member for unlocking the data storage device in an opposite direction with respect to the first direction.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: February 24, 2009
    Assignees: Hong Fu Jin Precision Industry (ShenZhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.
    Inventors: Xue-Cheng Zhang, Hao Lan, Pin-Shian Wu, Qin Guo, Chun-Chi Liang
  • Patent number: 7488826
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: February 10, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye
  • Publication number: 20090036940
    Abstract: An example relates to a method for sensing a pulmonary artery pressure (PAP) and providing a sensed PAP signal, detecting an abnormal blood pressure (BP) condition using information from the sensed PAP signal, delivering a pacing energy to a heart, and automatically altering at least one pacing characteristic in response to the detected abnormal BP condition. The detecting an abnormal BP condition can include detecting various forms of hypertension or hypotension. The automatically altering the at least one pacing characteristic can include automatically altering at least one of a pacing rate, a pacing waveform, an atriventricular (AV) delay, an interventricular (VV) delay, a pacing mode, or a pacing site. The method can also include delivering vagal nerve stimulation and automatically altering the vagal nerve stimulation in response to the detected abnormal BP condition. The detecting the abnormal BP condition can also include using a sensed auxiliary physiological parameter.
    Type: Application
    Filed: August 3, 2007
    Publication date: February 5, 2009
    Applicant: Cardiac Pacemakers, Inc
    Inventors: Xuan Wei, Cheng Zhang, Shantha Arcot-Krishnamurthy, Dan Li
  • Publication number: 20080312257
    Abstract: The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: wherein X1, X2, R1, R2, R3 and R4 are as defined herein, and their methods of preparation and use as ADP inhibitors.
    Type: Application
    Filed: October 31, 2007
    Publication date: December 18, 2008
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye, Cailin Chen
  • Publication number: 20080306044
    Abstract: The present invention is directed to a compound of Formula (I) or a form thereof: wherein U, V, W and Ring A are as defined herein, useful as vasopressin receptor antagonists.
    Type: Application
    Filed: June 6, 2008
    Publication date: December 11, 2008
    Inventors: MICHAEL J. COSTANZO, David F. McComsey, Stephen C. Yabut, Han-Cheng Zhang
  • Patent number: 7439363
    Abstract: The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I): R2 is selected from the group consisting of —C1-8alkyl-Z, —C2-8alkenyl-Z and —C2-8alkynyl-Z; wherein the —C1-8alkyl-Z, —C2-8alkenyl-Z and —C2-8alkynyl-Z and Z is a 5 to 6 member aromatic monocyclic heteroaryl ring having from 2 to 4 heteroatoms. These compounds are useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: October 21, 2008
    Assignee: Janssen Parmaceutica N.V.
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye